pt141 bremelanotide PT-141 (Bremelanotide) PT-141 | FancyMeds

The success of the Shared Savings Program notwithstanding, we explained in the CY 2025 PFS proposed rule (89 FR 61852) that targeting a subset of beneficiaries with specific diseases or conditions who received care from entities participating in certain disease- or condition-specific models and allowing them to more easily align to those entities will lead to better care and outcomes

Weve included a cost comparison table below to help you evaluate pricing across all products: Note: All prices are based on the brands website unless otherwise marked as Amazon, which offered a better value at the time of writing

2006;85(Suppl 1):121622

& Qu, J

G.BullockR.et al